Loading data for RHHBF — first visit, this takes a few seconds.

Roche Holding AG (RHHBF)

OTC Markets OTCQX: RHHBF · 실시간 가격 · USD

440.00

-27.00 (-5.78%)

종가 기준: Sep 01, 2026, 10:00 AM

알림

Alert

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

-5.78% (1D)

매수호가	436
시가총액	348B
매출 (ttm)	63B
순이익 (ttm)	12.3B
	0.35
	18.92
	23.07
	29.41
P/B (ttm)	8.62
P/S (ttm)	5.52
실적 발표일	n/a

매도호가	459.34
거래량	3
평균 거래량 (20일)	104
시가	440.00
전일 종가	467.00
일중 범위	440.00 - 440.00
52주 범위	301.27 - 514.08
애널리스트	n/a
목표주가	n/a
배당	$12.40 (2.73%)
배당락일	Mar 12, 2026

RHHBF 소개

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for ...

[더 보기]

산업 Drug Manufacturers - General

섹터 Healthcare

IPO 일자 Aug 3, 2012

직원 수 n/a

상장 거래소 OTC Markets OTCQX

티커 RHHBF

웹사이트 https://www.roche.com

전체 기업 정보

재무 실적

2025년 Roche의 매출은 63.36B로, 전년 62.4B 대비 1.54% 증가했습니다. 순이익은 12.88B로, 55.61% 증가했습니다.

재무제표

어닝 서프라이즈

Roche가 Invalid Date에 분기 실적을 발표했습니다:

매출 n/a 예상치 하회 $0, 및 NaN% 전년 대비 성장.
EPS 예상치 하회 , 및 NaN% 전년 대비 성장.

주가가 움직인 이유

뉴스

4일 전 · Simply Wall St.

Roche Holding (SWX:ROP) Secures FDA Clearance For Alzheimer’s Blood Test

Roche Holding (SWX:ROP) received FDA approval for its Elecsys pTau217 blood test for Alzheimer's disease in the U.S. The Elecsys pTau217 test is designed to identify amyloid pathology using a blood sa...

4일 전 · Barrons.com

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna’s Big Win

BioNTech says it’s ending a Phase 2 trial for its investigational personalized mRNA cancer vaccine. It was being tested to treat colorectal cancer.

4일 전 · GuruFocus.com

BioNTech Kills a Cancer Trial Roche Helped Build

One colorectal failure does not destroy the platform, but it exposes how brutally tumor biology can defeat elegant technology.

4일 전 · Stocktwits

BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt — BMO Capital Terms It ‘Clear Setback’

BioNTech said on Friday that it and its partner, Genentech, a Roche unit, are ending the mid-stage study of autogene cevumeran, used alone after surgery, in certain high-risk stage II or III colorecta...

5일 전 · Zacks

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.

2 페이지 중 1

Roche Holding AG (RHHBF)